Lv11
40 积分 2025-02-01 加入
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
8天前
已完结
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
2个月前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
4个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
4个月前
已完结
皖公网安备34019202002308
